« Previous
Next »
Titles
- Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system1
- Warming blankets and patient harm1
- We can do better: New York State residents weigh in on health care quality1
- Weaknesses exist in Medicaid managed care organizations' efforts to identify and address fraud and abuse1
- What are the implications for Medicare of the American Health Care Act and the Better Care Reconciliation Act?1
- What are the implications for Medicare of the American Health Care Act?1
- What are the possible effects of failing to extend the community health center fund?1
- What can the United States learn from pharmaceutical spending controls in France?1
- What could U.S. budget cuts mean for global health?1
- What could a Medicaid per capita cap mean for low-income people on Medicare?1
- What do Americans think about their health coverage ahead of the 2020 election?: findings from the Commonwealth Fund Health Insurance in America Survey : March–June 20191
- What explains attitudes toward the individual mandate?1
- What explains support for or opposition to Medicare for all?1
- What factors explain the decline in widows' poverty?1
- What financial risks do retirees face in late life?1
- What is at stake for health and health care disparities under ACA repeal?1
- What is at stake in ACA repeal and replace for people with HIV?1
- What is the impact on enrollment and premiums if the duration of short-term health insurance plans is increased?1
- What is the status of women's health and health care in the U.S. compared to ten other countries?1
- What is “affordable” health care?: a review of concepts to guide policymakers1